Metvix-based PDT for basal cell carcinoma and actinic keratosis - horizon scanning review

Record ID 32002000542
Authors' objectives:

To summarise the current research evidence on Metvix-based photodynamic therapy (PDT) for basal cell carcinoma (BCC) and actinic keratosis.

Authors' recommendations: - Clinical impact: The clinical advantages of Metvix-PDT appear to be small in the treatment of BCC compared to current treatment, but with markedly superior cosmetic results. The published clinical trials are small or in abstract form. - Service impact: There will be some service impact associated with the introduction of Metvix-PDT as equipment to generate the light and staff training will be needed. Metvix-PDT will replace other therapies such as cryotherapy, radiotherapy or surgical excision so freeing resources. - Additional factors: There may be increasing patient interest in Metvix-PDT as it produces a better cosmetic result than current treatments. - Financial and overall NHS impact: Due to the lack of comparative cost data, it is difficult to estimate the likely financial impact of the introduction of Metvix-PDT, but use in BCC it is likely to be small (0.9M GBP pa). The costs associated with Metvix-PDT for actinic keratosis may prove to be significant (4.7M - 9.4M GBP pa).
Authors' methods: Overview
Project Status: Completed
Year Published: 2002
URL for published report:
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Photochemotherapy
  • Carcinoma, Basal Cell
  • Photosensitivity Disorders
Organisation Name: NIHR Horizon Scanning Centre
Contact Address: The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health and Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United Kingdom. Tel: +44 121 414 7831, Fax: +44 121 2269
Contact Name:
Contact Email:
Copyright: National Horizon Scanning Centre (NHSC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.